RxDoctor Payments Data

Olga Beresneva, MD

Colon & Rectal Surgery · Boston, MANPI 1114345741

Payments from drug & device makers

What this record shows

This record is dominated by education: $28,292 of the $29,914 with a category attached, or 94.6%. 3 manufacturers reported payments, led by Intuitive Surgical at 56.7% of the total. 2025 is the largest year on record at $12,933, 9.2 times the $1,401 reported in 2019.

$29,914in general payments, 2019–2025

Across 38 payments — averaging $787.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$17K
  • Olympus Corporation Of The Americas$13K
  • Medtronic$40
$18,362in research payments, 2019–2025

Across 7 payments — averaging $2623.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$18K

What the payments were for

  • Travel & lodging$1,0303%
  • Food & beverage$5762%
  • Education$28,29295%
  • Gifts$160%

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical19$16,963
Olympus Corporation Of The Americas17$12,911
Medtronic2$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,914 in reported general payments places this provider in the 80th percentile of 49 colon & rectal surgery providers in Massachusetts.

See all colon & rectal surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$44,947
Medicare patients
106
Services billed
307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other colon & rectal surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →